Company intelligence / Profile preview

LeukoLifeDx

Huntington Beach, California, United Statespmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Commercial

Overview

LeukoLifeDx has developed a gene expression-based diagnostic assay for advanced heart failure, with proof-of-concept data showing 96% accuracy in predicting patient survival outcomes. The technology is protected by an issued US patent and is being validated in a planned 500-patient clinical study. The platform aims to guide treatment decisions by identifying high-risk patients who may not benefit from surgery, potentially saving lives and reducing healthcare costs. Research is also ongoing into applications for long COVID outcome prediction using similar technology.

Therapeutic areas: CardiovascularInfectious Diseases
Modalities: Gene expression profilingGenomic assayDiagnostic test kit
Industry: Molecular Diagnostics

Drug pipeline

1 asset

MyLeukoMAP

Commercial

Indications: Heart failure, COVID-19

Partnerships

No major pharmaceutical or biotech partnerships disclosed; seeking collaborations with academic institutions and other diagnostic companies.

Beyond the preview

Go deeper on LeukoLifeDx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LeukoLifeDx.

Explore the full profile